Effective Lowering of Lipoprotein (a) - A New Frontier in CardiovascularRisk Reduction

Authors

Institutions

Publication Details

Journal
Cardiovascular & Haematological Disorders - Drug Targets
Published
2026-06-30
DOI
https://doi.org/10.2174/011871529x520042260627210331
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effective Lowering of Lipoprotein (a) - A New Frontier in CardiovascularRisk Reduction

Debabrata Mukherjee, Richard A. Lange
Cardiovascular & Haematological Disorders - Drug Targets
Lipoproteins and Cardiovascular Health
article

Effective Lowering of Lipoprotein (a) - A New Frontier in CardiovascularRisk Reduction

Debabrata Mukherjee, Richard A. Lange
article en

Abstract

No abstract available for this paper.
Cardiovascular & Haematological Disorders - Drug TargetsVol. 26
Texas Tech University (US), The University of Texas at El Paso (US), Texas Tech University Health Sciences Center (US)
Good health and well-being
Openalex Percentile: Top 6%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effective Lowering of Lipoprotein (a) - A New Frontier in CardiovascularRisk Reduction — Debabrata Mukherjee, Richard A. Lange · Cardiovascular & Haematological Disorders - Drug Targets (2026) | TGRS Research Map | TGRS